You have 9 free searches left this month | for more free features.

AML

Showing 1 - 25 of 2,911

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • chidamide and azacitidine
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 27, 2023

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)

Not yet recruiting
  • AML, Adult
  • Biological characterization of AML with MECOM or atypical 3q26 rearrangements
  • (no location specified)
Apr 21, 2023

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Assessment of Geriatric Evaluations Impact on New AML Guidance

Not yet recruiting
  • AML, Adult
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 12, 2023

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

    Not yet recruiting
    • AML, Adult
    • Pharmacoscopy
    • Clinical standard-of-care (physician's choice)
    • (no location specified)
    Nov 20, 2023

    Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • MCBC regimen
    • Bu/Cy regimen
    • (no location specified)
    Nov 13, 2023

    AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

    Recruiting
    • AML
    • Image-based ex-vivo drug screening platform (pharmacoscopy)
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Feb 8, 2023

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

    Not yet recruiting
    • Relapsed/Refractory AML
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Mar 28, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    AML, Adult, Minimal Residual Disease Trial (MRD assessment)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • MRD assessment
    • (no location specified)
    Oct 13, 2023

    Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Nantes, France
      CHU de Nantes
    Jan 24, 2023

    Immunophenotyping of Blast Cells and Immune Effector Cells in

    Completed
    • Leukemia
    • Blood and Marrow sample
    • Marseille, France
      Assistance Publique - Hopitaux de Marseille
    Jan 23, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

      Recruiting
      • Bortezomib
      • Acute Myeloid Leukemia
      • DAG pre-excitation regimen with Bortezomib
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Jul 31, 2023

      AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

      Not yet recruiting
      • AML, Adult
      • Minimal Residual Disease
      • CD33/CLL1 dual CAR-NK cell
      • +5 more
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Aug 4, 2023

      AML Trial in Beijing (IM23)

      Completed
      • AML
      • Beijing, China
        Xian Lu
      Jan 18, 2023

      AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

      Recruiting
      • AML, Adult
      • CLL1 CAR-NK cell injection
      • Hangzhou, Zhejiang, China
        Clinical research ethics committee of the first affiliated hospi
      Aug 30, 2023

      Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

      Active, not recruiting
      • Acute Myeloid Leukemia (AML)
      • Nantes, France
        CHU of Nantes
      Dec 16, 2022

      Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Mar 15, 2023

      Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

      Not yet recruiting
      • Relapsed Acute Myeloid Leukaemia
      • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
      • (no location specified)
      Jul 4, 2023

      Essential Hypertension Trial (AZM X mg + AML Y mg, AZM X mg + AML Y' mg, AZM X' mg + AML Y mg)

      Not yet recruiting
      • Essential Hypertension
      • AZM X mg + AML Y mg
      • +7 more
      • (no location specified)
      May 25, 2022